Clinical observation during alemtuzumab administration

Allen, Christopher M., Feng, Jenny J., Willis, Mark D. ORCID: https://orcid.org/0000-0003-3024-6063, McGinley, Marisa, Ontaneda, Daniel, Tallantyre, Emma C. ORCID: https://orcid.org/0000-0002-3760-6634 and Evangelou, Nikos 2020. Clinical observation during alemtuzumab administration. Multiple Sclerosis and Related Disorders 37 , 101412. 10.1016/j.msard.2019.101412

Preview

PDF - Accepted Post-Print Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (108kB) | Preview

Abstract

• Alemtuzumab has been associated with stroke and cervicocephalic dissections. • Monitoring blood pressure is currently recommended by the EMA. • Monitoring blood pressure is not useful in predicting these rare side effects.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Medicine Research Institutes & Centres > MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Publisher:	Elsevier
ISSN:	2211-0348
Date of First Compliant Deposit:	26 March 2020
Date of Acceptance:	25 September 2019
Last Modified:	24 Nov 2024 12:00
URI:	https://orca.cardiff.ac.uk/id/eprint/130591

Citation Data

Cited 25 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item